Graphene-based enzyme-modified field-effect transistor biosensor for monitoring drug effects in Alzheimer's disease treatment

Myung Sic Chae, Yong Kyoung Yoo, Jinsik Kim, Tae Geun Kim, Kyo Seon Hwang

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

A reduced graphene oxide-based enzyme-modified field-effect transistor (RGO-EnFET) was fabricated to study the enzymatic kinetics between acetylcholinesterase (AChE) and acetylcholine (ACh), which are related to the progression and treatment of Alzheimer's disease (AD). The RGO-EnFET exhibited typical ambipolar transfer characteristics with a charge neutrality point (the Dirac point, VDirac) in an aqueous environment, and biological events occurring on the RGO surface were evaluated by observing the Dirac point shift (ΔVDirac) according to reactions. First, the pH sensitivity of the RGO-EnFET was measured to be 24.12 mV pH−1 for a pH range of 4–10 with excellent repeatability. Then, ACh quantification in the concentration range of 1 μM–10 mM was evaluated, with a linear slope of 13.9 mV dec−1 being obtained between ΔVDirac and the ACh concentration on a logarithmic scale. The effects of AChE inhibitors (donepezil and rivastigmine) on the AChE enzymatic activity were also investigated. The distinguishable inhibition rates were acquired for donepezil and rivastigmine at saturation levels of 90% and 75%, respectively. These results indicate that the RGO-EnFET biosensor was successfully exploited as an in vitro analytical tool and has potential of future application in the study of enzymatic kinetics and drug screening for therapeutic purposes.

Original languageEnglish
Pages (from-to)448-458
Number of pages11
JournalSensors and Actuators, B: Chemical
Volume272
DOIs
Publication statusPublished - 2018 Nov 1

Fingerprint

Graphite
Rivastigmine
acetylcholine
Field effect transistors
bioinstrumentation
Biosensors
Oxides
Graphene
enzymes
graphene
drugs
field effect transistors
Enzymes
Acetylcholine
oxides
Monitoring
Acetylcholinesterase
Pharmaceutical Preparations
Kinetics
Cholinesterase Inhibitors

Keywords

  • Acetylcholine
  • Acetylcholinesterase inhibitor
  • Alzheimer's disease
  • Biosensor
  • Reduced graphene oxide

ASJC Scopus subject areas

  • Electronic, Optical and Magnetic Materials
  • Instrumentation
  • Condensed Matter Physics
  • Surfaces, Coatings and Films
  • Metals and Alloys
  • Electrical and Electronic Engineering
  • Materials Chemistry

Cite this

Graphene-based enzyme-modified field-effect transistor biosensor for monitoring drug effects in Alzheimer's disease treatment. / Chae, Myung Sic; Yoo, Yong Kyoung; Kim, Jinsik; Kim, Tae Geun; Hwang, Kyo Seon.

In: Sensors and Actuators, B: Chemical, Vol. 272, 01.11.2018, p. 448-458.

Research output: Contribution to journalArticle

@article{d3fa816eb55745888d83b51904004fff,
title = "Graphene-based enzyme-modified field-effect transistor biosensor for monitoring drug effects in Alzheimer's disease treatment",
abstract = "A reduced graphene oxide-based enzyme-modified field-effect transistor (RGO-EnFET) was fabricated to study the enzymatic kinetics between acetylcholinesterase (AChE) and acetylcholine (ACh), which are related to the progression and treatment of Alzheimer's disease (AD). The RGO-EnFET exhibited typical ambipolar transfer characteristics with a charge neutrality point (the Dirac point, VDirac) in an aqueous environment, and biological events occurring on the RGO surface were evaluated by observing the Dirac point shift (ΔVDirac) according to reactions. First, the pH sensitivity of the RGO-EnFET was measured to be 24.12 mV pH−1 for a pH range of 4–10 with excellent repeatability. Then, ACh quantification in the concentration range of 1 μM–10 mM was evaluated, with a linear slope of 13.9 mV dec−1 being obtained between ΔVDirac and the ACh concentration on a logarithmic scale. The effects of AChE inhibitors (donepezil and rivastigmine) on the AChE enzymatic activity were also investigated. The distinguishable inhibition rates were acquired for donepezil and rivastigmine at saturation levels of 90{\%} and 75{\%}, respectively. These results indicate that the RGO-EnFET biosensor was successfully exploited as an in vitro analytical tool and has potential of future application in the study of enzymatic kinetics and drug screening for therapeutic purposes.",
keywords = "Acetylcholine, Acetylcholinesterase inhibitor, Alzheimer's disease, Biosensor, Reduced graphene oxide",
author = "Chae, {Myung Sic} and Yoo, {Yong Kyoung} and Jinsik Kim and Kim, {Tae Geun} and Hwang, {Kyo Seon}",
year = "2018",
month = "11",
day = "1",
doi = "10.1016/j.snb.2018.06.010",
language = "English",
volume = "272",
pages = "448--458",
journal = "Sensors and Actuators, B: Chemical",
issn = "0925-4005",
publisher = "Elsevier",

}

TY - JOUR

T1 - Graphene-based enzyme-modified field-effect transistor biosensor for monitoring drug effects in Alzheimer's disease treatment

AU - Chae, Myung Sic

AU - Yoo, Yong Kyoung

AU - Kim, Jinsik

AU - Kim, Tae Geun

AU - Hwang, Kyo Seon

PY - 2018/11/1

Y1 - 2018/11/1

N2 - A reduced graphene oxide-based enzyme-modified field-effect transistor (RGO-EnFET) was fabricated to study the enzymatic kinetics between acetylcholinesterase (AChE) and acetylcholine (ACh), which are related to the progression and treatment of Alzheimer's disease (AD). The RGO-EnFET exhibited typical ambipolar transfer characteristics with a charge neutrality point (the Dirac point, VDirac) in an aqueous environment, and biological events occurring on the RGO surface were evaluated by observing the Dirac point shift (ΔVDirac) according to reactions. First, the pH sensitivity of the RGO-EnFET was measured to be 24.12 mV pH−1 for a pH range of 4–10 with excellent repeatability. Then, ACh quantification in the concentration range of 1 μM–10 mM was evaluated, with a linear slope of 13.9 mV dec−1 being obtained between ΔVDirac and the ACh concentration on a logarithmic scale. The effects of AChE inhibitors (donepezil and rivastigmine) on the AChE enzymatic activity were also investigated. The distinguishable inhibition rates were acquired for donepezil and rivastigmine at saturation levels of 90% and 75%, respectively. These results indicate that the RGO-EnFET biosensor was successfully exploited as an in vitro analytical tool and has potential of future application in the study of enzymatic kinetics and drug screening for therapeutic purposes.

AB - A reduced graphene oxide-based enzyme-modified field-effect transistor (RGO-EnFET) was fabricated to study the enzymatic kinetics between acetylcholinesterase (AChE) and acetylcholine (ACh), which are related to the progression and treatment of Alzheimer's disease (AD). The RGO-EnFET exhibited typical ambipolar transfer characteristics with a charge neutrality point (the Dirac point, VDirac) in an aqueous environment, and biological events occurring on the RGO surface were evaluated by observing the Dirac point shift (ΔVDirac) according to reactions. First, the pH sensitivity of the RGO-EnFET was measured to be 24.12 mV pH−1 for a pH range of 4–10 with excellent repeatability. Then, ACh quantification in the concentration range of 1 μM–10 mM was evaluated, with a linear slope of 13.9 mV dec−1 being obtained between ΔVDirac and the ACh concentration on a logarithmic scale. The effects of AChE inhibitors (donepezil and rivastigmine) on the AChE enzymatic activity were also investigated. The distinguishable inhibition rates were acquired for donepezil and rivastigmine at saturation levels of 90% and 75%, respectively. These results indicate that the RGO-EnFET biosensor was successfully exploited as an in vitro analytical tool and has potential of future application in the study of enzymatic kinetics and drug screening for therapeutic purposes.

KW - Acetylcholine

KW - Acetylcholinesterase inhibitor

KW - Alzheimer's disease

KW - Biosensor

KW - Reduced graphene oxide

UR - http://www.scopus.com/inward/record.url?scp=85048205913&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048205913&partnerID=8YFLogxK

U2 - 10.1016/j.snb.2018.06.010

DO - 10.1016/j.snb.2018.06.010

M3 - Article

AN - SCOPUS:85048205913

VL - 272

SP - 448

EP - 458

JO - Sensors and Actuators, B: Chemical

JF - Sensors and Actuators, B: Chemical

SN - 0925-4005

ER -